lidocaine 40 MG/ML Topical Cream [LMX]

RxCUI
1422103
RxNorm name
lidocaine 40 MG/ML Topical Cream [LMX]
Display name
LMX (Topical)
Full name
lidocaine 40 MG/ML Topical Cream [LMX]
Term type
SBD
Status
Active
Strength
4%
Dose form
Cream
Route
Topical
Updated
2026-07-30 22:38:59

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062013
Active start
062013
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
lidocaine40 MG / 1 MLlidocainelidocaine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Cream316982

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
lidocaine6387

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRL-M-X-4 4 % Topical CreamNAMES
RxNorm Namelidocaine 40 MG/ML Topical Cream [LMX]NAMES
RxNorm SynonymL-M-X-4 4 % Topical CreamNAMES
RxNorm SynonymL-M-X-4 40 MG/ML Topical CreamNAMES
RxNorm SynonymLMX 40 MG/ML Topical CreamNAMES
TTYSBDATTRIBUTES
SPL_SET_IDf0e7c92f-8b0b-4045-b659-af9f6e81260fCODES
RxCUI1422103CODES
MMSL_CODEBD22841CODES
MMSL_CODEBD6735CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0496-0882-060496-0882LMX4 lidocaineFerndale Laboratories, Inc.M017
0496-0882-070496-0882LMX4 lidocaineFerndale Laboratories, Inc.M017
0496-0882-150496-0882LMX4 lidocaineFerndale Laboratories, Inc.M017
0496-0882-300496-0882LMX4 lidocaineFerndale Laboratories, Inc.M017
0496-0882-710496-0882LMX4 lidocaineFerndale Laboratories, Inc.M017

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M0170496-0882LMX4 lidocaineOTC MONOGRAPH DRUGFerndale Laboratories, Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 14 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00496088206rxnav_ndcsyes
00496088207rxnav_ndcsyes
00496088215rxnav_ndcsyes
00496088230rxnav_ndcsyes
00496088271rxnav_ndcsyes
00496082305rxnav_historical_indirect
00496082306rxnav_historical_indirect
00496082307rxnav_historical_indirect
00496082308rxnav_historical_indirect
00496082315rxnav_historical_indirect
00496082330rxnav_historical_indirect
00496088205rxnav_historical_indirect
00496088208rxnav_historical_indirect
55045370501rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LMX4LIDOCAINEFerndale Laboratories, Inc.f0e7c92f-8b0b-4045-b659-af9f6e81260f2025-12-10WarningsExact identifier
ndc (package): 0496-0882-06
ndc (package): 0496-0882-71
ndc (package): 0496-0882-07
ndc (package): 0496-0882-30
ndc (package): 0496-0882-15
ndc (product): 0496-0882
ndc11 (package): 00496088205
ndc11 (package): 00496088207
ndc11 (package): 00496088206
ndc11 (package): 00496088215
ndc11 (package): 00496088271
ndc11 (package): 00496088230
rxcui: 1422103

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f0e7c92f-8b0b-4045-b659-af9f6e81260fL-M-X-4 40 MG/ML Topical CreamSY6L.M.X.420251210
f0e7c92f-8b0b-4045-b659-af9f6e81260flidocaine 40 MG/ML Topical Cream [LMX]SBD6L.M.X.420251210
f0e7c92f-8b0b-4045-b659-af9f6e81260fL-M-X-4 4 % Topical CreamPSN6L.M.X.420251210
f0e7c92f-8b0b-4045-b659-af9f6e81260fLMX 40 MG/ML Topical CreamSY6L.M.X.420251210
f0e7c92f-8b0b-4045-b659-af9f6e81260fL-M-X-4 4 % Topical CreamSY6L.M.X.420251210

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f0e7c92f-8b0b-4045-b659-af9f6e81260fL.M.X.4Ferndale Laboratories, Inc.20251210
06d35deb-53ef-4057-83b7-5ece6b46a5feNational Council for Prescription Drug Programs20120724
22ebe846-b69c-48b8-b5ce-be3599d1376bNational Council for Prescription Drug Programs20120724
54d93ce4-7bf8-4116-be6f-74ac7102655bNational Council for Prescription Drug Programs20120724
7da3a277-b0cc-4ca0-b933-24f121dd0d08National Council for Prescription Drug Programs20120724
9a795358-5f11-441b-b27d-ef3adcb2e574National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH40 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD22841
CODESMMSL_CODEBD6735
CODESRxCUI1422103
CODESSPL_SET_IDf0e7c92f-8b0b-4045-b659-af9f6e81260f
NAMESPrescribable SynonymL-M-X-4 4 % Topical Cream
NAMESRXNAV_STRL-M-X-4 4 % Topical Cream
NAMESRxNorm Namelidocaine 40 MG/ML Topical Cream [LMX]
NAMESRxNorm SynonymL-M-X-4 4 % Topical Cream
NAMESRxNorm SynonymL-M-X-4 40 MG/ML Topical Cream
NAMESRxNorm SynonymLMX 40 MG/ML Topical Cream
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon